Clinical Trials in Philadelphia

Showing 1401-1420 of 9,968 trials

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

NCT05735743

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

End Stage Renal Disease on Dialysis

Vanderbilt University Medical Center176 participantsStarted Oct 2023

Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States • Philadelphia, PA 19123, Pennsylvania, United States +3 more locations

COMPLETEDNA< 1 mile

A Peer-Led Intervention to Improve Postpartum Retention in HIV Care

NCT04168008

The purpose of this study is to test the efficacy of a theory-driven peer intervention for pregnant and postpartum women living HIV. The peer intervention is designed to increase self-efficacy, social support, self-regulatory behaviors, and outcome expectancy in order to improve retention in care and viral suppression postpartum. The intervention will consist of face-to-face prenatal educational sessions, starting in early third trimester, and postpartum sessions scheduled up to three months postpartum.

HIV/AIDS

University of Pennsylvania151 participantsStarted Mar 2020

Birmingham, Alabama, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +4 more locations

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

A Peer-Led Intervention to Improve Postpartum Retention in HIV Care

Find Trials by Condition in Philadelphia

SyncAV Post-Market Trial

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Multisite Virtual Reality Intervention for Speech Anxiety

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)